Skip to main content
Clinical Trials/NCT05044104
NCT05044104CompletedNot Applicable

A Prospective Study of the Role and Accuracy of Consumer-Facing Wearable Technology in Gastrointestinal Endoscopy

Mayo Clinic1 site in 1 country292 target enrollmentStarted: January 11, 2022Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
292
Locations
1
Primary Endpoint
Recorded Bradycardia Events

Study Overview

Brief Summary

Researchers are assessing the accuracy and safety of wearable technology in subjects undergoing endoscopic gastrointestinal procedures with sedation.

Detailed Description

This is a prospective, non-blinded, exploratory study to assess the accuracy and safety of wearable devices in the endoscopy suite with patients undergoing procedures using anesthesia assisted sedation using smart watches. We will also simultaneously perform an assessment of patient and provider preferences using narrative-driven, qualitative evaluation.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Supportive Care
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Adults over 18 years of age.
  • •Undergoing anesthesia-assisted endoscopic procedures.
  • •Able to give appropriate consent to the study or have an appropriate representative to do so.

Exclusion Criteria

  • •Pregnancy.
  • •Physical deformity, wound, or dressing preventing placement of a wearable device on the wrist.
  • •Allergy to aluminum, nickel or acrylate.

Arms & Interventions

Wearable technology in endoscopic gastrointestinal procedures with sedation

Experimental

Subjects undergoing a endoscopic gastrointestinal procedure with sedation as part of standard of care will wear a consumer-facing wearable smart watch for the duration of the procedure.

Intervention: Consumer-facing wearable smart watch (Device)

Outcomes

Primary Outcomes

Recorded Bradycardia Events

Time Frame: Anesthesia Duration, approximately 30 to 45 minutes

Number of bradycardia events recorded as defined as heart rate \< 60 bpm

Recorded Arrhythmia Events

Time Frame: Anesthesia Duration, approximately 30 to 45 minutes

Number of arrhythmia events recorded

Recorded Desaturation Events

Time Frame: Anesthesia Duration, approximately 30 to 45 minutes

Number of desaturation events recorded as defined as peripheral O2 saturation \<88%

Recorded Tachycardia Events

Time Frame: Anesthesia Duration, approximately 30 to 45 minutes

Number of tachycardia events recorded as defined as heart rate \> 100 bpm

Recorded Tachypnea

Time Frame: Anesthesia Duration, approximately 30 to 45 minutes

Number of tachypnea events recorded as defined as respiratory rate \>18 breaths per minute

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Vinay Chandrasekhara

Principal Investigator

Mayo Clinic

Study Sites (1)

Loading locations...

Similar Trials